Modern methods for delivery of drugs across the blood-brain barrier.

[1]  Zhirong Zhang,et al.  Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. , 2011, International journal of pharmaceutics.

[2]  Chun-Hua Wang,et al.  Baicalin Inhibits TLR2/4 Signaling Pathway in Rat Brain Following Permanent Cerebral Ischemia , 2011, Inflammation.

[3]  Qin He,et al.  Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  Xinguo Jiang,et al.  Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease. , 2011, International journal of pharmaceutics.

[5]  M. Nonnemacher,et al.  Breaking down the barrier: The effects of HIV-1 on the blood–brain barrier , 2011, Brain Research.

[6]  W. Luk,et al.  Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target , 2011, Science Translational Medicine.

[7]  H. Stolp,et al.  Effects of Neonatal Systemic Inflammation on Blood-Brain Barrier Permeability and Behaviour in Juvenile and Adult Rats , 2011, Cardiovascular psychiatry and neurology.

[8]  W. Hennink,et al.  Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[9]  David W. Holman,et al.  The blood-brain barrier, chemokines and multiple sclerosis. , 2011, Biochimica et biophysica acta.

[10]  P. Couraud,et al.  Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  David F. Moore,et al.  Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: What should be the policy? , 2011, NeuroImage.

[12]  Kaan E. Biron,et al.  Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE , 2010, Journal of Neuroimmunology.

[13]  R. Faull,et al.  ABC efflux transporters in brain vasculature of Alzheimer's subjects , 2010, Brain Research.

[14]  Rianne Stam,et al.  Electromagnetic fields and the blood–brain barrier , 2010, Brain Research Reviews.

[15]  Rongqin Huang,et al.  Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Dora Brites,et al.  Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches , 2010, Brain Research Reviews.

[17]  C. Bode,et al.  Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI. , 2010, Contrast media & molecular imaging.

[18]  S. Saxena,et al.  Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: Implications for HIV-1-associated neurocognitive disorder , 2010, Journal of NeuroVirology.

[19]  Houfu Liu,et al.  Central Nervous System Penetration for Small Molecule Therapeutic Agents Does Not Increase in Multiple Sclerosis- and Alzheimer's Disease-Related Animal Models Despite Reported Blood-Brain Barrier Disruption , 2010, Drug Metabolism and Disposition.

[20]  M A Vandelli,et al.  Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[21]  Yu-rong Li,et al.  The role of protein kinase C in the opening of blood-brain barrier induced by electromagnetic pulse. , 2010, Toxicology.

[22]  T. Kusaka,et al.  The expression of LDL receptor in vessels with blood–brain barrier impairment in a stroke-prone hypertensive model , 2010, Histochemistry and Cell Biology.

[23]  Rajiv Chopra,et al.  Antibodies Targeted to the Brain with Image-Guided Focused Ultrasound Reduces Amyloid-β Plaque Load in the TgCRND8 Mouse Model of Alzheimer's Disease , 2010, PloS one.

[24]  Lanjuan Li,et al.  The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis. , 2010, Biomaterials.

[25]  Vasilis Ntziachristos,et al.  Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging , 2010, Particle and Fibre Toxicology.

[26]  V. Nerurkar,et al.  Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor. , 2010, Virology.

[27]  Hao-Li Liu,et al.  Opening of the blood-brain barrier by low-frequency (28-kHz) ultrasound: a novel pinhole-assisted mechanical scanning device. , 2010, Ultrasound in medicine & biology.

[28]  R. Gabathuler,et al.  Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases , 2010, Neurobiology of Disease.

[29]  Yunman Li,et al.  Blood brain barrier permeability and therapeutic time window of Ginkgolide B in ischemia-reperfusion injury. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[30]  A. Palmer.  The role of the blood–CNS barrier in CNS disorders and their treatment , 2010, Neurobiology of Disease.

[31]  Chen Jiang,et al.  Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. , 2009, Biomaterials.

[32]  P. Steeg,et al.  Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer , 2009, Pharmaceutical Research.

[33]  Z. Fu,et al.  Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection. , 2009, Virus research.

[34]  E. Kiyatkin,et al.  Permeability of the blood–brain barrier depends on brain temperature , 2009, Neuroscience.

[35]  H. Gendelman,et al.  Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS1 , 2009, The Journal of Immunology.

[36]  D. Begley,et al.  Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Eugene S. Lee,et al.  Molecular mechanisms of endothelial hyperpermeability: implications in inflammation , 2009, Expert Reviews in Molecular Medicine.

[38]  Q. Ping,et al.  Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. , 2009, International journal of pharmaceutics.

[39]  W. Pardridge,et al.  Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology. , 2009, Molecular pharmaceutics.

[40]  M. Deli,et al.  Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. , 2009, Biochimica et biophysica acta.

[41]  Austin S Nakatsuka,et al.  West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier. , 2009, Virology.

[42]  H. Maeda,et al.  Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[43]  G. Schenk,et al.  Differential receptor-mediated drug targeting to the diseased brain , 2009, Expert opinion on drug delivery.

[44]  Wei Lu,et al.  Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[45]  J. Kreuter,et al.  Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[46]  Brandoch D. Cook,et al.  TGF‐β1 induces rearrangement of FLK‐1–VE‐cadherin–β‐catenin complex at the adherens junction through VEGF‐mediated signaling , 2008, Journal of cellular biochemistry.

[47]  Kinam Park.  Trojan monocytes for improved drug delivery to the brain. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[48]  G. Golomb,et al.  Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[49]  W. Brown,et al.  Increased expression of β-catenin in brain microvessels of a segmentally trisomic (Ts65Dn) mouse model of Down syndrome , 2008, Brain cell biology.

[50]  A. Kabanov,et al.  Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[51]  F. Dromer,et al.  Evidence of a Role for Monocytes in Dissemination and Brain Invasion by Cryptococcus neoformans , 2008, Infection and Immunity.

[52]  G. Schenk,et al.  Drug targeting to the brain , 2008, Annual review of pharmacology and toxicology.

[53]  Alexander V Kabanov,et al.  Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[54]  A. Małecki,et al.  Physiology and pharmacological role of the blood-brain barrier. , 2008, Pharmacological reports : PR.

[55]  R. Béliveau,et al.  Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep‐2 , 2008, British journal of pharmacology.

[56]  R. Keep,et al.  Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier , 2008, Current neuropharmacology.

[57]  J. Scherrmann,et al.  CNS Delivery Via Adsorptive Transcytosis , 2008, The AAPS Journal.

[58]  Natalia Vykhodtseva,et al.  Progress and problems in the application of focused ultrasound for blood-brain barrier disruption. , 2008, Ultrasonics.

[59]  R. Béliveau,et al.  Involvement of the low‐density lipoprotein receptor‐related protein in the transcytosis of the brain delivery vector Angiopep‐2 , 2008, Journal of neurochemistry.

[60]  S. Hladky,et al.  Activation of β‐catenin signalling by GSK‐3 inhibition increases p‐glycoprotein expression in brain endothelial cells , 2008, Journal of neurochemistry.

[61]  Kullervo Hynynen,et al.  Ultrasound for drug and gene delivery to the brain. , 2008, Advanced drug delivery reviews.

[62]  M. Yano,et al.  Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells , 2008, Journal of NeuroVirology.

[63]  Y. Kuo,et al.  Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers. , 2008, International journal of pharmaceutics.

[64]  Michel Demeule,et al.  Identification and Design of Peptides as a New Drug Delivery System for the Brain , 2008, Journal of Pharmacology and Experimental Therapeutics.

[65]  L. González-Mariscal,et al.  Crosstalk of tight junction components with signaling pathways. , 2008, Biochimica et biophysica acta.

[66]  A. Tiwary,et al.  Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: In vitro and in vivo evaluation , 2008, Acta pharmaceutica.

[67]  F. Yin,et al.  [Effect of lysophosphatidic acid increase the permeability of blood-brain barrier model]. , 2008, Zhonghua yi xue za zhi.

[68]  J. Nutt,et al.  Strategies to advance translational research into brain barriers , 2008, The Lancet Neurology.

[69]  Y. Kajimoto,et al.  Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: a modality for boron neutron capture therapy , 2008, Journal of Neuro-Oncology.

[70]  B. Zlokovic.  The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.

[71]  D. V. Kohli,et al.  Transferrin-conjugated liposomal system for improved delivery of 5-fluorouracil to brain , 2008 .

[72]  H. Harashima,et al.  Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes. , 2007, International journal of pharmaceutics.

[73]  J. Beckmann,et al.  Cell-permeable peptides induce dose- and length-dependent cytotoxic effects. , 2007, Biochimica et biophysica acta.

[74]  Win-Li Lin,et al.  Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption. , 2007, Ultrasound in medicine & biology.

[75]  Natalia Vykhodtseva,et al.  Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI‐guided focused ultrasound , 2007, International journal of cancer.

[76]  Jing Qin,et al.  Surface modification of RGD-liposomes for selective drug delivery to monocytes/neutrophils in brain. , 2007, Chemical & pharmaceutical bulletin.

[77]  E. Shusta,et al.  Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation , 2007, Pharmaceutical Research.

[78]  M. Ricci,et al.  Solid lipid nanoparticles for targeted brain drug delivery. , 2007, Advanced drug delivery reviews.

[79]  B. Davidson,et al.  Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.

[80]  David Eidelberg,et al.  Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial , 2007, The Lancet.

[81]  J. Kaye,et al.  Blood–brain barrier impairment in Alzheimer disease , 2007, Neurology.

[82]  James Haorah,et al.  Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood–brain barrier dysfunction , 2007, Journal of neurochemistry.

[83]  Imad Najm,et al.  Seizure‐Promoting Effect of Blood–Brain Barrier Disruption , 2007, Epilepsia.

[84]  Xinguo Jiang,et al.  Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[85]  P. Carvey,et al.  Blood–Brain Barrier Pathology in Alzheimer's and Parkinson's Disease: Implications for Drug Therapy , 2007, Cell transplantation.

[86]  T. Nishioku,et al.  An Inhibitory Role of Nitric Oxide in the Dynamic Regulation of the Blood-Brain Barrier Function , 2007, Cellular and Molecular Neurobiology.

[87]  W. Pardridge,et al.  Humanization of anti‐human insulin receptor antibody for drug targeting across the human blood–brain barrier , 2007, Biotechnology and bioengineering.

[88]  C. Ek,et al.  Changes in blood–brain barrier permeability to large and small molecules following traumatic brain injury in mice , 2007, The European journal of neuroscience.

[89]  J. Scherrmann,et al.  Applications of a Blood-Brain Barrier Technology Platform to Predict CNS Penetration of Various Chemotherapeutic Agents. 2. Cationic Peptide Vectors for Brain Delivery , 2007, Chemotherapy.

[90]  Raoul Kopelman,et al.  Brain cancer diagnosis and therapy with nanoplatforms. , 2006, Advanced drug delivery reviews.

[91]  P. Gaillard,et al.  A novel opportunity for targeted drug delivery to the brain. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[92]  M. Seelbach,et al.  Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain , 2006, Brain Research.

[93]  T. Gardner,et al.  VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. , 2006, Investigative ophthalmology & visual science.

[94]  G. Schettini,et al.  Expression of CXC chemokine receptors 1–5 and their ligands in human glioma tissues: Role of CXCR4 and SDF1 in glioma cell proliferation and migration , 2006, Neurochemistry International.

[95]  S. Yuan.  New insights into eNOS signaling in microvascular permeability. , 2006, American journal of physiology. Heart and circulatory physiology.

[96]  R. Tamargo,et al.  Inflammation in stroke and focal cerebral ischemia. , 2006, Surgical neurology.

[97]  A. Mildner,et al.  Circulating monocytes engraft in the brain, differentiate into microglia and contribute to the pathology following meningitis in mice. , 2006, Brain : a journal of neurology.

[98]  J. van Marle,et al.  Limited contribution of claudin-5-dependent tight junction strands to endothelial barrier function. , 2006, European journal of cell biology.

[99]  Manabu Kinoshita,et al.  Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[100]  J. Haorah,et al.  Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions , 2006, Journal of Neuroimmune Pharmacology.

[101]  L. Fenart,et al.  Methylated β-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood–brain barrier , 2006 .

[102]  E. Kılıç,et al.  Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia , 2006, Nature Neuroscience.

[103]  R. Cecchelli,et al.  How cyclodextrins can mask their toxic effect on the blood-brain barrier. , 2006, Bioorganic & medicinal chemistry letters.

[104]  L. Tsai,et al.  Blood-brain barrier dysfunction occurring in mice infected with Angiostrongylus cantonensis. , 2006, Acta tropica.

[105]  T. Suhara,et al.  Pharmacokinetics and brain uptake of lactoferrin in rats. , 2006, Life sciences.

[106]  S. Steinberg,et al.  Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children’s Oncology Group , 2006, Cancer Chemotherapy and Pharmacology.

[107]  D. Holtzman,et al.  IgG-Assisted Age-Dependent Clearance of Alzheimer's Amyloid β Peptide by the Blood–Brain Barrier Neonatal Fc Receptor , 2005, The Journal of Neuroscience.

[108]  A. Levitzki,et al.  EGF Receptor-Targeted Synthetic Double-Stranded RNA Eliminates Glioblastoma, Breast Cancer, and Adenocarcinoma Tumors in Mice , 2005, PLoS medicine.

[109]  A. Fagan,et al.  P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. , 2005, The Journal of clinical investigation.

[110]  T. Postolache,,et al.  Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge , 2005, Neurological research.

[111]  Maria Lindgren,et al.  Cell-penetrating peptides: a comparative membrane toxicity study. , 2005, Analytical biochemistry.

[112]  D. Cheresh,et al.  Tyrosine Phosphorylation of VE-cadherin Prevents Binding of p120- and β-Catenin and Maintains the Cellular Mesenchymal State* , 2005, Journal of Biological Chemistry.

[113]  W. Jiskoot,et al.  Strategies for cytosolic delivery of liposomal macromolecules. , 2005, International journal of pharmaceutics.

[114]  P. Couvreur,et al.  Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? , 2005, International journal of pharmaceutics.

[115]  M. Morris,et al.  Cell-penetrating peptides: tools for intracellular delivery of therapeutics , 2005, Cellular and Molecular Life Sciences CMLS.

[116]  A. Minagar,et al.  Elevated endothelial microparticle—monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-β1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes , 2005, Multiple sclerosis.

[117]  R. D. Lynch,et al.  Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. , 2005, American journal of physiology. Cell physiology.

[118]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[119]  W. Pardridge.  Molecular biology of the blood-brain barrier , 2005, Methods in molecular medicine.

[120]  W. Jefferies,et al.  Development of a potential protein vector (NeuroTrans) to deliver drugs across the blood–brain barrier , 2005 .

[121]  W. Pardridge,et al.  Drug and gene targeting to the brain via blood–brain barrier receptor-mediated transport systems , 2005 .

[122]  A. Boer,et al.  Diphtheria toxin receptor-targeted brain drug delivery , 2005 .

[123]  T. Tsuruo,et al.  Brain pericytes contribute to the induction and up-regulation of blood–brain barrier functions through transforming growth factor-β production , 2005, Brain Research.

[124]  Ulo Langel,et al.  Cell-penetrating peptides: mechanism and kinetics of cargo delivery. , 2005, Advanced drug delivery reviews.

[125]  J. Bart,et al.  Blood–brain barrier dysfunction in parkinsonian midbrain in vivo , 2005, Annals of neurology.

[126]  Masami Niwa,et al.  Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology , 2005, Cellular and Molecular Neurobiology.

[127]  Yong Woo Lee,et al.  Mechanisms of the Blood–Brain Barrier Disruption in HIV-1 Infection , 2005, Cellular and Molecular Neurobiology.

[128]  N. Abbott.  Dynamics of CNS Barriers: Evolution, Differentiation, and Modulation , 2005, Cellular and Molecular Neurobiology.

[129]  Swadeshmukul Santra,et al.  Synthesis of water-dispersible fluorescent, radio-opaque, and paramagnetic CdS:Mn/ZnS quantum dots: a multifunctional probe for bioimaging. , 2005, Journal of the American Chemical Society.

[130]  J. Kamps,et al.  Cell-Specific Targeting of Lipid-Based Carriers for ODN and DNA , 2005, Journal of liposome research.

[131]  L. Fenart,et al.  Effects of γ- and Hydroxypropyl-γ-cyclodextrins on the Transport of Doxorubicin across an in Vitro Model of Blood-Brain Barrier , 2004, Journal of Pharmacology and Experimental Therapeutics.

[132]  A. Kabanov,et al.  Effect of Pluronic P85 on ATPase Activity of Drug Efflux Transporters , 2004, Pharmaceutical Research.

[133]  J. Temsamani,et al.  The use of cell-penetrating peptides for drug delivery. , 2004, Drug discovery today.

[134]  T. Yamashita,et al.  Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. , 2004, Experimental cell research.

[135]  D. Ray,et al.  Reversible disruption of tight junction complexes in the rat blood‐brain barrier, following transitory focal astrocyte loss , 2004, Glia.

[136]  H. Benson,et al.  Drug delivery across the blood-brain barrier. , 2004, Current drug delivery.

[137]  R. Bendayan,et al.  Functional Expression and Localization of P-glycoprotein in the Central Nervous System: Relevance to the Pathogenesis and Treatment of Neurological Disorders , 2004, Pharmaceutical Research.

[138]  Willem Boogerd,et al.  Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours? , 2004, Cancer treatment reviews.

[139]  L. Fenart,et al.  Behavior of α-, β-, and γ-Cyclodextrins and Their Derivatives on an in Vitro Model of Blood-Brain Barrier , 2004, Journal of Pharmacology and Experimental Therapeutics.

[140]  K. Hynynen,et al.  Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. , 2004, Ultrasound in medicine & biology.

[141]  Chaobin He,et al.  Cholesteryl-grafted functional amphiphilic poly(N-isopropylacrylamide-co-N-hydroxylmethylacrylamide): synthesis, temperature-sensitivity, self-assembly and encapsulation of a hydrophobic agent. , 2004, Biomaterials.

[142]  C. Morisi,et al.  CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patients , 2004, Cancer Immunology, Immunotherapy.

[143]  S. Simões,et al.  Improving lipoplex-mediated gene transfer into C6 glioma cells and primary neurons , 2004, Experimental Neurology.

[144]  D. Begley,et al.  ABC transporters and the blood-brain barrier. , 2004, Current pharmaceutical design.

[145]  K. Jin,et al.  Post-ischemic Administration of Heparin-Binding Epidermal Growth Factor-like Growth Factor (HB-EGF) Reduces Infarct Size and Modifies Neurogenesis after Focal Cerebral Ischemia in the Rat , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[146]  Steven F. Dowdy,et al.  Cell Penetrating Peptides in Drug Delivery , 2004, Pharmaceutical Research.

[147]  Steven F Dowdy,et al.  Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.

[148]  E. Morgan,et al.  The Metabolism of Neuronal Iron and Its Pathogenic Role in Neurological Disease: Review , 2004, Annals of the New York Academy of Sciences.

[149]  H. Galla,et al.  Tyrosine phosphatase inhibition induces loss of blood–brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways , 2004, Brain Research.

[150]  Yiguang Jin,et al.  The Effect of RMP-7 and its Derivative on Transporting Evens Blue Liposomes into the Brain , 2004, Drug delivery.

[151]  Alireza Minagar,et al.  Blood-brain barrier disruption in multiple sclerosis , 2003, Multiple sclerosis.

[152]  R. Keep,et al.  Iron and Iron-Handling Proteins in the Brain After Intracerebral Hemorrhage , 2003, Stroke.

[153]  A. Rees,et al.  Studies on the Internalization Mechanism of Cationic Cell-penetrating Peptides* , 2003, Journal of Biological Chemistry.

[154]  Sanyog Jain,et al.  RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting. , 2003, International journal of pharmaceutics.

[155]  G. Pasternak,et al.  Improved Brain Uptake and Pharmacological Activity of Dalargin Using a Peptide-Vector-Mediated Strategy , 2003, Journal of Pharmacology and Experimental Therapeutics.

[156]  C. Borlongan,et al.  Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport , 2003, Brain Research Bulletin.

[157]  M. Balda,et al.  Holey barrier , 2003, The Journal of cell biology.

[158]  S. Tsukita,et al.  Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.

[159]  D. Janigro,et al.  Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy. , 2003, Current drug targets.

[160]  W. Pardridge.  Blood-brain barrier drug targeting: the future of brain drug development. , 2003, Molecular interventions.

[161]  K. Hynynen,et al.  The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison). , 2003, Ultrasound in medicine & biology.

[162]  M. Giacca,et al.  HIV Tat, its TARgets and the control of viral gene expression. , 2003, FEMS microbiology letters.

[163]  Jayanth Panyam,et al.  Dynamics of Endocytosis and Exocytosis of Poly(D,L-Lactide-co-Glycolide) Nanoparticles in Vascular Smooth Muscle Cells , 2003, Pharmaceutical Research.

[164]  A. Fasano,et al.  Zonula occludens toxin increases the permeability of molecular weight markers and chemotherapeutic agents across the bovine brain microvessel endothelial cells. , 2003, Journal of pharmaceutical sciences.

[165]  W. Pardridge,et al.  Marked enhancement in gene expression by targeting the human insulin receptor , 2003, The journal of gene medicine.

[166]  Donald W. Miller,et al.  Optimal Structure Requirements for Pluronic Block Copolymers in Modifying P-glycoprotein Drug Efflux Transporter Activity in Bovine Brain Microvessel Endothelial Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.

[167]  Alexander V Kabanov,et al.  Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. , 2003, Advanced drug delivery reviews.

[168]  A. Schinkel,et al.  Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. , 2003, Advanced drug delivery reviews.

[169]  E. Lo,et al.  Junctional complexes of the blood–brain barrier: permeability changes in neuroinflammation , 2002, Progress in Neurobiology.

[170]  H. Wekerle.  Immune protection of the brain--efficient and delicate. , 2002, The Journal of infectious diseases.

[171]  E. Kılıç,et al.  Intravenous TAT–Bcl‐Xl is protective after middle cerebral artery occlusion in mice , 2002, Annals of neurology.

[172]  S. Yuan.  Protein kinase signaling in the modulation of microvascular permeability. , 2002, Vascular pharmacology.

[173]  Michel Demeule,et al.  High transcytosis of melanotransferrin (P97) across the blood–brain barrier , 2002, Journal of neurochemistry.

[174]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[175]  Fabrice Chrétien,et al.  Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. , 2002, The Journal of infectious diseases.

[176]  R. Dermietzel,et al.  Angiogenesis of the blood‐brain barrier in vitro and the function of cerebral pericytes , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[177]  F. Sharp,et al.  In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis , 2002, The Journal of Neuroscience.

[178]  粟秀初.  Fungal meningitis , 2002 .

[179]  Ralph Weissleder,et al.  Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. , 2002, Bioconjugate chemistry.

[180]  A. Wierinckx,et al.  Interferon-β directly influences monocyte infiltration into the central nervous system , 2002, Journal of Neuroimmunology.

[181]  Hartwig Wolburg,et al.  Tight junctions of the blood-brain barrier: development, composition and regulation. , 2002, Vascular pharmacology.

[182]  Ling Xie,et al.  Alzheimer's β-Amyloid Peptides Compete for Insulin Binding to the Insulin Receptor , 2002, The Journal of Neuroscience.

[183]  P. Fraser,et al.  The role of guanylyl cyclases in the permeability response to inflammatory mediators in pial venular capillaries in the rat , 2002, The Journal of physiology.

[184]  W. Pardridge,et al.  Drug and gene targeting to the brain with molecular trojan horses , 2002, Nature Reviews Drug Discovery.

[185]  R. Egleton,et al.  Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier , 2001, Trends in Neurosciences.

[186]  R. Bendayan,et al.  Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. , 2001, Pharmacological reviews.

[187]  Xavier Alvarez,et al.  Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system , 2001, Glia.

[188]  D. Strickland,et al.  LRP: a multifunctional scavenger and signaling receptor. , 2001, The Journal of clinical investigation.

[189]  K. Hynynen,et al.  Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. , 2001, Radiology.

[190]  H. Lei,et al.  Tumour necrosis factor-α causes an increase in blood-brain barrier permeability during sepsis , 2001 .

[191]  P. Couvreur,et al.  Long-Circulating PEGylated Polycyanoacrylate Nanoparticles as New Drug Carrier for Brain Delivery , 2001, Pharmaceutical Research.

[192]  R. Rybak,et al.  Intravenous Infusion of Cereport Increases Uptake and Efficacy of Acyclovir in Herpes Simplex Virus-Infected Rat Brains , 2001, Antimicrobial Agents and Chemotherapy.

[193]  E. Ling,et al.  Cellular inflammatory response associated with breakdown of the blood-brain barrier after closed head injury in rats. , 2001, Journal of neurotrauma.

[194]  S. Tsukita,et al.  Regulation of Tight Junction Permeability and Occludin Phosphorylation by RhoA-p160ROCK-dependent and -independent Mechanisms* , 2001, The Journal of Biological Chemistry.

[195]  R. Egleton,et al.  Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. , 2001, American journal of physiology. Heart and circulatory physiology.

[196]  Donald W. Miller,et al.  Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. , 2001, The Journal of pharmacology and experimental therapeutics.

[197]  W. Pardridge,et al.  Conjugation of brain-derived neurotrophic factor to a blood–brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin , 2001, Brain Research.

[198]  D. Holtzman,et al.  Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. , 2000, The Journal of clinical investigation.

[199]  L. Tetley,et al.  Niosomes and Polymeric Chitosan Based Vesicles Bearing Transferrin and Glucose Ligands for Drug Targeting , 2000, Pharmaceutical Research.

[200]  R. Bartus,et al.  Intravenous Cereport (RMP-7) Enhances Delivery of Hydrophilic Chemotherapeutics and Increases Survival in Rats with Metastatic Tumors in the Brain , 2000, Pharmaceutical Research.

[201]  A. P. Soler,et al.  Protein kinase C activation leads to dephosphorylation of occludin and tight junction permeability increase in LLC-PK1 epithelial cell sheets. , 2000, Journal of cell science.

[202]  R. Bartus,et al.  Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival. , 2000, The Journal of pharmacology and experimental therapeutics.

[203]  D. Craig,et al.  The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. , 2000, International journal of pharmaceutics.

[204]  N. Abbott.  Inflammatory Mediators and Modulation of Blood–Brain Barrier Permeability , 2000, Cellular and Molecular Neurobiology.

[205]  P. Stewart.  Endothelial Vesicles in the Blood–Brain Barrier: Are They Related to Permeability? , 2000, Cellular and Molecular Neurobiology.

[206]  C. Rousselle,et al.  New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. , 2000, Molecular pharmacology.

[207]  B. Engelhardt,et al.  Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. , 2000, The Journal of pharmacology and experimental therapeutics.

[208]  E. Morgan,et al.  Transferrin and Transferrin Receptor Function in Brain Barrier Systems , 2000, Cellular and Molecular Neurobiology.

[209]  David Fortin,et al.  Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood‐brain barrier for the treatment of patients with malignant brain tumors , 2000, Cancer.

[210]  M. Freeman,et al.  A nontoxic diphtheria toxin analogue inhibits neonatal bladder smooth muscle cell proliferation. , 2000, The Journal of urology.

[211]  M. Fromm,et al.  P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. , 2000, International journal of clinical pharmacology and therapeutics.

[212]  R. Cecchelli,et al.  Tumor Necrosis Factor‐α Increases Lactoferrin Transcytosis Through the Blood‐Brain Barrier , 1999 .

[213]  C. Achim,et al.  Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. , 1999, The American journal of pathology.

[214]  S. Schwarze,et al.  In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.

[215]  A. Gregor,et al.  Phase II Studies of RMP-7 and Carboplatin in the Treatment of Recurrent High Grade Glioma , 1999, Journal of Neuro-Oncology.

[216]  Alexander V. Kabanov,et al.  Pluronic P85 Increases Permeability of a Broad Spectrum of Drugs in Polarized BBMEC and Caco-2 Cell Monolayers , 1999, Pharmaceutical Research.

[217]  R. Bartus,et al.  Cereport™ (RMP-7) Increases the Permeability of Human Brain Microvascular Endothelial Cell Monolayers1 , 1999, Pharmaceutical Research.

[218]  R. Bartus,et al.  Enhanced delivery of carboplatin into brain tumours with intravenous CereportTM (RMP-7): dramatic differences and insight gained from dosing parameters , 1999, British Journal of Cancer.

[219]  S. Higashiyama,et al.  Heparin-binding epidermal growth factor-like growth factor mRNA expression in neonatal rat brain with hypoxic/ischemic injury , 1999, Brain Research.

[220]  I. Tamai,et al.  Carrier-mediated or specialized transport of drugs across the blood-brain barrier. , 1999, Advanced drug delivery reviews.

[221]  L. Fenart,et al.  Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier* , 1999, The Journal of Biological Chemistry.

[222]  K. Mishima,et al.  The Gene for Heparin-Binding Epidermal Growth Factor-Like Growth Factor is Stress-Inducible: Its Role in Cerebral Ischemia , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[223]  M. Moeschberger,et al.  Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7). , 1999, Neurosurgery.

[224]  M. Mattson,et al.  Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Hippocampus: Modulation of Expression by Seizures and Anti-Excitotoxic Action , 1999, The Journal of Neuroscience.

[225]  Natalie A. Lissy,et al.  Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration , 1998, Nature Medicine.

[226]  R. Dermietzel,et al.  Regulation of a Blood-Brain Barrier—Specific Enzyme Expressed by Cerebral Pericytes (Pericytic Aminopeptidase N/pAPN) under Cell Culture Conditions , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[227]  Alexander V. Kabanov,et al.  Effects of Pluronic P85 Unimers and Micelles on Drug Permeability in Polarized BBMEC and Caco-2 Cells , 1998, Pharmaceutical Research.

[228]  F. Bloom,et al.  Central analgesic actions of loperamide following transient permeation of the blood brain barrier with Cereport™ (RMP-7) 1 Published on the World Wide Web on 30 June 1998. 1 , 1998, Brain Research.

[229]  J. Szejtli.  Introduction and General Overview of Cyclodextrin Chemistry. , 1998, Chemical reviews.

[230]  M. Klagsbrun,et al.  Heparin-binding EGF-like growth factor. , 1997, Biochimica et biophysica acta.

[231]  A. Kabanov,et al.  Interactions of pluronic block copolymers with brain microvessel endothelial cells: evidence of two potential pathways for drug absorption. , 1997, Bioconjugate chemistry.

[232]  L. Fenart,et al.  A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier , 1997, The Journal of cell biology.

[233]  D. Trombetta,et al.  Changes in the permeability of the blood-brain barrier following sodium dodecyl sulphate administration in the rat , 1997, Experimental Brain Research.

[234]  W. Pardridge,et al.  Drug Delivery to the Brain , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[235]  Robert Langer,et al.  PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics1 , 1997 .

[236]  L. Rubin,et al.  Lysophosphatidic Acid Increases Tight Junction Permeability in Cultured Brain Endothelial Cells , 1997, Journal of neurochemistry.

[237]  M. Santucci,et al.  Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. , 1996, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[238]  W. Paulus,et al.  Distribution and characterization of microglia/macrophages in human brain tumors , 1996, Acta Neuropathologica.

[239]  Y. Miyagi,et al.  Regional distribution of heparin-binding epidermal growth factor-like growth factor mRNA and protein in adult rat forebrain , 1996, Neuroscience Letters.

[240]  H. von Briesen,et al.  Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro , 1996, Antimicrobial agents and chemotherapy.

[241]  H. Ito,et al.  Sequential changes in cerebral blood flow, early neuropathological consequences and blood-brain barrier disruption following radiofrequency-induced localized hyperthermia in the rat. , 1996, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[242]  G. Curran,et al.  Polyamine Modification Increases the Permeability of Proteins at the Blood‐Nerve and Blood‐Brain Barriers , 1996, Journal of neurochemistry.

[243]  I. Romero,et al.  Transporting therapeutics across the blood-brain barrier. , 1996, Molecular medicine today.

[244]  Bernhard A. Sabel,et al.  Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections , 1996, Brain Research.

[245]  R. Bartus,et al.  Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7 , 1995, Brain Research.

[246]  M. Woodle,et al.  Sterically stabilized liposome therapeutics , 1995 .

[247]  Lisbeth Illum,et al.  Long circulating microparticulate drug carriers , 1995 .

[248]  W. Pardridge,et al.  Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[249]  W. Pardridge,et al.  Human Insulin Receptor Monoclonal Antibody Undergoes High Affinity Binding to Human Brain Capillaries in Vitro and Rapid Transcytosis Through the Blood–Brain Barrier in Vivo in the Primate , 1995, Pharmaceutical Research.

[250]  D. Bazile,et al.  Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. , 1995, Journal of pharmaceutical sciences.

[251]  J. Kerwin,et al.  Transferrin receptors in the normal human hippocampus and in Alzheimer's disease , 1994, Neuropathology and applied neurobiology.

[252]  Erwin G. Van Meir,et al.  Human astrocytomas and glioblastomas express monocyte chemoattractant protein‐1 (MCP‐1) in vivo and in vitro , 1994, International journal of cancer.

[253]  P. Hof,et al.  The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis , 1994, Brain Research.

[254]  Streit Wj.  Cellular immune response in brain tumors. , 1994 .

[255]  M. Fukui,et al.  Intracarotid histamine infusion increases blood tumour permeability in RG2 glioma. , 1994, Neurological research.

[256]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[257]  J Barsoum,et al.  Tat-mediated delivery of heterologous proteins into cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[258]  M. Hope,et al.  The influence of size and composition on the cholesterol mobilizing properties of liposomes in vivo. , 1993, Biochimica et biophysica acta.

[259]  R. Schmidt,et al.  Bone marrow-derived elements in the peripheral nervous system. An immunohistochemical and ultrastructural investigation in chimeric rats. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[260]  R. Kalaria,et al.  Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease , 1992, Brain Research.

[261]  R. Liburdy,et al.  Permeability of the Blood‐Brain Barrier of the Rat Is Not Significantly Altered by NMR Exposure a , 1992, Annals of the New York Academy of Sciences.

[262]  James M. Anderson,et al.  The tight-junction-specific protein ZO-l is a component of the human and rat blood-brain barriers , 1991, Neuroscience Letters.

[263]  A. Betz,et al.  Oleic acid reversibly opens the blood-brain barrier , 1991, Brain Research.

[264]  M. Salcman,et al.  Blood-brain barrier alteration after microwave-induced hyperthermia is purely a thermal effect: I. Temperature and power measurements. , 1991, Surgical neurology.

[265]  E. Vivés,et al.  Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1 , 1991 .

[266]  F. Prato,et al.  Magnetic resonance imaging increases the blood-brain barrier permeability to 153-gadolinium diethylenetriaminepentaacetic acid in rats , 1990, Brain Research.

[267]  L. Recht,et al.  Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. , 1990, Journal of neurosurgery.

[268]  D. Papahadjopoulos,et al.  Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. , 1990, Biochimica et biophysica acta.

[269]  E. Preston,et al.  Does magnetic resonance imaging compromise integrity of the blood-brain barrier? , 1989, Neuroscience Letters.

[270]  W. Pardridge,et al.  Human blood-brain barrier transferrin receptor. , 1987, Metabolism: clinical and experimental.

[271]  Frank S. Prato,et al.  Magnetic resonance imaging temporarily alters blood-brain barrier permeability in the rat , 1987, Neuroscience Letters.

[272]  T. Ogawa,et al.  Chemical composition and immunobiological activities of sodium dodecyl sulphate extracts from the cell envelopes of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Fusobacterium nucleatum. , 1987, Journal of general microbiology.

[273]  W. Pardridge,et al.  Human Blood—Brain Barrier Insulin Receptor , 1985, Journal of neurochemistry.

[274]  I. Fidler,et al.  Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon , 1985, Cancer Immunology, Immunotherapy.

[275]  I. Fidler,et al.  Human monocytes activated by immunomodulators in liposomes lyse herpesvirus-infected but not normal cells. , 1984, Science.

[276]  R. Rappuoli,et al.  The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197. , 1984, Nucleic acids research.

[277]  S. Michaelson,et al.  Effect of 2450 MHz microwave energy on the blood-brain barrier to hydrophilic molecules. D. Brain temperature and blood-brain barrier permeability to hydrophilic tracers , 1984, Brain Research Reviews.

[278]  S. Michaelson,et al.  Effect of 2450 MHz microwave energy on the blood—brain barrier to hydrophilic molecules. A. Effect on the permeability to sodium fluorescein , 1984, Brain Research Reviews.

[279]  P. Anderson.  Antibody Responses to Haemophilus influenzae Type b and Diphtheria Toxin Induced by Conjugates of Oligosaccharides of the Type b Capsule with the Nontoxic Protein CRM197 , 1983, Infection and immunity.

[280]  E. Albert,et al.  Reversible microwave effects on the blood-brain barrier , 1981, Brain Research.

[281]  K. Gollahon,et al.  Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. , 1979, Journal of neurosurgery.

[282]  K. Gollahon,et al.  Macrophages in experimental and human brain tumors. Part 1: Studies of the macrophage content of experimental rat brain tumors of varying immunogenicity. , 1979, Journal of neurosurgery.

[283]  W. Oldendorf,et al.  The large apparent work capability of the blood‐brain barrier: A study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat , 1977, Annals of neurology.

[284]  R. Katzman.,et al.  3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrier , 1975 .

[285]  W. Löscher,et al.  Blood-brain barrier active efflux transporters: ATP-binding cassette gene family , 2011, NeuroRX.

[286]  Woo Hyeun Kang,et al.  TAT Is Not Capable of Transcellular Delivery Across an Intact Endothelial Monolayer In Vitro , 2010, Annals of Biomedical Engineering.

[287]  F. Ahmad,et al.  CNS drug delivery systems: novel approaches. , 2009, Recent patents on drug delivery & formulation.

[288]  K. Foust,et al.  Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes , 2009, Nature Biotechnology.

[289]  S. Moochhala,et al.  Polymeric micelles anchored with TAT for delivery of antibiotics across the blood-brain barrier. , 2008, Biopolymers.

[290]  R. Egleton,et al.  Pathophysiology of the blood-brain barrier: animal models and methods. , 2008, Current topics in developmental biology.

[291]  Rongqin Huang,et al.  Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain. , 2007, Journal of biomedical science.

[292]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[293]  W. Rogers,et al.  Factors regulating macrophage endocytosis of nanoparticles: implications for targeted magnetic resonance plaque imaging. , 2005, Atherosclerosis.

[294]  Francisco González-Scarano,et al.  The neuropathogenesis of AIDS , 2005, Nature Reviews Immunology.

[295]  Peter Vajkoczy,et al.  Vascular microenvironment in gliomas. , 2004, Cancer treatment and research.

[296]  M. Cipolla,et al.  Transcellular transport as a mechanism of blood-brain barrier disruption during stroke. , 2004, Frontiers in bioscience : a journal and virtual library.

[297]  A. Vorbrodt,et al.  Molecular anatomy of interendothelial junctions in human blood-brain barrier microvessels. , 2004, Folia histochemica et cytobiologica.

[298]  R. Shivers,et al.  Heat stress affects blood-brain barrier permeability to horseradish peroxidase in mice , 2004, Acta Neuropathologica.

[299]  B. McEwen,et al.  Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. , 2001, Annual review of pharmacology and toxicology.

[300]  K. Jellinger,et al.  Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease , 1998, Journal of Neural Transmission.

[301]  M. Fukui,et al.  Effect of histamine on the blood-tumor barrier in transplanted rat brain tumors. , 1994, Acta neurochirurgica. Supplementum.

[302]  S. Suga,et al.  Effect of barrier opening on brain edema in human brain tumors. , 1994, Acta neurochirurgica. Supplementum.

[303]  A. Coombes,et al.  Resorbable polymeric microspheres for drug delivery--production and simultaneous surface modification using PEO-PPO surfactants. , 1994, Biomaterials.

[304]  D. Lange,et al.  Japanese encephalitis virus (JEV): potentiation of lethality in mice by microwave radiation. , 1991, Bioelectromagnetics.

[305]  R. Quock,et al.  Microwave facilitation of domperidone antagonism of apomorphine-induced stereotypic climbing in mice. , 1987, Bioelectromagnetics.

[306]  J. C. Lin,et al.  Microwave hyperthermia-induced blood-brain barrier alterations. , 1982, Radiation research.

[307]  E. Hersh,et al.  Uptake of liposomes and liposome-encapsulated muramyl dipeptide by human peripheral blood monocytes. , 1982, Journal of the Reticuloendothelial Society.

[308]  M. Rescigno,et al.  Review the Gut Immune Barrier and the Blood-brain Barrier: Are They so Different? , 2022 .